AntibioticMech

Browse · ANTIBACTERIAL

PR-39

CHEBI:131850 ·resolve ·ANTIBACTERIAL ·EXACT REVIEWED

A 39 amino acid porcine cathelicidin that is rich in proline and arginine residues. It plays a pivotal role in the innate immune defence of the pig against infections and exhibits antimicrobial and immunomodulatory activities. — ChEBI

Classification

Strictly broader compounds or drug classes this molecule belongs to.

Chemical structure

Computed structure properties
Molecular formulaC229H345N69O41
Charge0
Average mass4720.721 Da
Monoisotopic mass4717.70324 Da
SourceChEBI
InChIKeyJTJJGVCUEGCBHL-IWDHFESKSA-N

SMILES

CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O

InChI

InChI=1S/C229H345N69O41/c1-7-135(6)181(218(337)297-122-50-89-178(297)216(335)283-108-33-72-161(283)190(309)261-132-180(300)262-157(128-137-54-15-9-16-55-137)206(325)293-118-46-84-173(293)212(331)284-109-37-77-166(284)192(311)265-146(65-26-98-254-223(237)238)185(304)276-158(129-138-56-17-10-18-57-138)207(326)294-119-47-85-174(294)213(332)286-111-39-78-167(286)193(312)266-147(66-27-99-255-224(239)240)186(305)277-160(131-140-60-21-12-22-61-140)209(328)298-123-51-90-179(298)219(338)339)279-187(306)148(67-28-100-256-225(241)242)267-194(313)168-79-40-112-287(168)211(330)172-83-45-117-292(172)205(324)156(125-134(4)5)274-184(303)145(64-25-97-253-222(235)236)264-191(310)165-76-38-110-285(165)214(333)175-86-48-120-295(175)208(327)159(130-139-58-19-11-20-59-139)278-189(308)153(126-136-52-13-8-14-53-136)272-198(317)170-81-42-114-289(170)215(334)177-88-49-121-296(177)217(336)176-87-44-116-291(176)203(322)152(71-32-104-260-229(249)250)271-196(315)163-74-35-106-281(163)201(320)150(69-30-102-258-227(245)246)269-197(316)164-75-36-107-282(164)204(323)155(124-133(2)3)275-188(307)154(127-141-91-93-142(299)94-92-141)273-199(318)169-80-41-113-288(169)210(329)171-82-43-115-290(171)202(321)151(70-31-103-259-228(247)248)270-195(314)162-73-34-105-280(162)200(319)149(68-29-101-257-226(243)244)268-183(302)144(63-24-96-252-221(233)234)263-182(301)143(230)62-23-95-251-220(231)232/h8-22,52-61,91-94,133-135,143-179,181,299H,7,23-51,62-90,95-132,230H2,1-6H3,(H,261,309)(H,262,300)(H,263,301)(H,264,310)(H,265,311)(H,266,312)(H,267,313)(H,268,302)(H,269,316)(H,270,314)(H,271,315)(H,272,317)(H,273,318)(H,274,303)(H,275,307)(H,276,304)(H,277,305)(H,278,308)(H,279,306)(H,338,339)(H4,231,232,251)(H4,233,234,252)(H4,235,236,253)(H4,237,238,254)(H4,239,240,255)(H4,241,242,256)(H4,243,244,257)(H4,245,246,258)(H4,247,248,259)(H4,249,250,260)/t135-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,181-/m0/s1

Also called

Cross-references

Identifiers for this same structure in other resources. An accession that lands on two different structures in this corpus is withheld from both rather than shown here, since it names at most one of them.

Activity roles

Every antimicrobial role a source asserts for this compound — the unreduced evidence behind its antimicrobial_class.

Source concepts

Every upstream concept that resolved to this record. The merge is the product: this is what shows ChEBI and CARD are describing the same structure.

Upstream concepts merged into this record
SourceNative IDLabelMinted CURIEVersion
CHEBI CHEBI:131850 PR-39 antibioticmech:chebi-43097ef537 2026-08-30

Molecular targets

The molecular entity or process this compound acts on. Each target carries evidence — this is a mechanistic claim, not a classification.

bacterial cytoplasmic membrane MEMBRANE ATTACKED_COMPONENT

Mature PR-39 caused ATP leakage and loss of membrane potential in B. globigii and E. coli; a separate Salmonella study observed killing without cell lysis, bounding the membrane-disruption interpretation. Evidence status: PRIMARY_EVIDENCE. Source: PRIMARY_LITERATURE 2014-04 (retrieved 2026-09-02).

SbmA peptide transporter PROTEIN SUSCEPTIBILITY_DETERMINANT

Independent Salmonella mutants with altered SbmA were about fourfold less susceptible and killed more slowly. This establishes a genetic susceptibility determinant, but the study did not directly measure peptide uptake or identify SbmA as the lethal binding target. Evidence status: PRIMARY_EVIDENCE. Source: PRIMARY_LITERATURE 2008-06 (retrieved 2026-09-02).

Mechanism summary

Mode of action
MEMBRANE_DISRUPTION host shared target — CURATOR: PMID:24755622 found that mature PR-39 caused ATP leakage and loss of membrane potential in Bacillus globigii and Escherichia coli. PMID:18519732 showed killing of Salmonella without overt cell lysis and identified SbmA loss-of-function mutations that reduced susceptibility. Together these data support membrane permeabilization/depolarization with SbmA-linked susceptibility, not universal gross lysis or directly measured SbmA-dependent uptake.

Resistance mechanisms

1 source-backed resistance determinants or associations, with ARO grounding where reported. Grouped by reported mechanism type.

OTHER 1
OTHER
DeterminantARO IDOrganismGene familiesEvidence
SbmA alterations reduce PR-39 susceptibility
Salmonella enterica serovar Typhimurium mutants with SbmA alterations were about fourfold less susceptible and showed slower killing without an obvious measured fitness cost. The study called SbmA a putative transport protein but did not directly measure uptake, so the specific resistance route remains unresolved. Aggregate of LT2-derived mutants, not one experimental allele. The LT2 reference-protein crosswalk is retained separately; no reference strain TaxID, protein accession or genome is assigned to the mutants. The source gene symbol sbmA is retained without variant-coordinate normalization.
— Salmonella enterica NCBITaxon:28901 sbmA sbmA
  • PMID:18519732 (Primary PR-39 resistance selection, genetic analysis, and fitness study.)
  • https://rest.uniprot.org/taxonomy/28901 (Taxonomic identity only: active species, UniProt release 2026_03; retrieved 2026-10-08 UTC.)
  • https://www.uniprot.org/uniprotkb/Q8ZRF5/entry (Reference-only UniProtKB:Q8ZRF5 (sbmA); UniProtKB unreviewed (TrEMBL), entry version 106, sequence version 1, release 2026_03; retrieved 2026-10-08. Reference organism NCBITaxon:99287, not an experimental subject assignment. Not an exact tested allele, altered protein, strain or genome identifier, and not independent phenotype or mechanism evidence. A component reference does not assign the effect of a combined genotype to that component. UniProt Consortium, CC BY 4.0.)

Record-level evidence

Curation history

  1. SEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Seeded from data/raw/ inventories (CHEBI)

  2. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  3. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  4. REVIEWED 2026-09-03 · codex · LLM-assisted

    Verified exact ChEBI peptide identity, structure, antimicrobial roles, and class; added membrane disruption with the non-lysis boundary and SbmA as an evidence-backed susceptibility/resistance determinant while preserving the unresolved uptake-mechanism gap.

  5. GROUNDED_RESISTANCE_CONTEXT 2026-10-08 · codex · LLM-assisted

    Grounded the existing aggregate claim to a verified species and clarified experimental versus reference context. No exact mutant protein, strain TaxID, genome, variant normalization or quantitative endpoint added.

  6. GROUNDED_RESISTANCE_REFERENCE_CITATIONS 2026-10-14 · codex · LLM-assisted

    Added qualified UniProt evidence citations for reference proteins already verified in the research dossier. Preserved all biological assertions, experimental identity fields, activities and existing evidence. Reference citations are not tested alleles, altered proteins or independent resistance evidence; no strain TaxID, genome, variant or quantitative endpoint added. Whole-record review remains open.

Provenance

Seeded by scripts/seed_from_sources.py from the committed inventories in data/raw/. View the record (YAML).

Explore across X-Mech: MediaIngredientMech (PR-39) · CultureMech · NaturalProductMech · PathwayMech · TraitMech